威扬酒业控股(08509.HK)与恒生银行订立融资函件 最高融资额8010万港元
格隆汇 3 月 12日丨威扬酒业控股(08509.HK)宣布,于2021年3月10日,公司全资附属公司威扬(酒业)有限公司("威扬(酒业)"(作为借方))、恒生银行有限公司("贷方"(作为贷方))及公司(作为担保人)订立银行融资函件。融资函件包含一项循环贷款、一项信贷融资及一张公司信用卡,最高融资额分别为5000万港元、3000万港元及10万港元,经贷方批准可根据融资函件所载条款及条件供威扬(酒业)使用,惟须经(其中包括)贷方随时审阅及受限于贷方按要求偿还之凌驾性权利,包括要求即时偿还潜在及或然负债之借贷款项之权利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.